75 The same NK1 receptor antagonist also exerted anxiolytic efficacy in rat social interDNA Damage antagonist action tests.76 As shown by microinjection experiments of NK1 receptor antagonists, the amygdala appears to be one of the sites of action.77 More evidence for the antidepressant activity of NK1 receptor antagonists is given by their modulation of the serotonergic and norepinephrinergic systems.

Systemic administration of an NK1 receptor antagonist enhances the firing rate of the locus ceruleus in response to stress.28 Recently, the activating effect of sustained NK1 receptor blockade on postsynaptic 5-HT1a autoreceptors was shown.78 The functional relationship between the NK1 receptor and the serotonergic system Inhibitors,research,lifescience,medical was also demonstrated by studies on NK1 knock-out mice. The constitutive lack of NK1 receptors appeared to be associated with a downregulation Inhibitors,research,lifescience,medical and functional desensitization of 5-HT1a autoreceptors. The serotonin receptor

subtype la has been suggested to be critically involved in antidepressant action of selective serotonin-reuptake inhibitors (SSRIs) and its downregulation and desensitization in NK1 knock-out Inhibitors,research,lifescience,medical mice is equivalent to the effect of chronic treatment with SSRT antidepressants.79 Studies using NK1 receptor antagonists are not the only ones to show the anxiolytic and antidepressant potency of antagonizing the tachykinin receptors. The selective blockade of the NK2 receptor Inhibitors,research,lifescience,medical also exhibited the potency of antidepressant-like action. A recently published study demonstrated the positive effect of the NK2 receptor antagonist SR48968 on the mobility in the forced swimming test in mice and rats, and on the maternal separation-induced vocalizations in guineapig pups. This behavioral effect was associated with a reduced separation-induced increase in the number of neurons displaying NK1 receptor internalization in the amygdala.80 In contrast, the NK3 receptor seems

Inhibitors,research,lifescience,medical to play a differential role in depression-like behavior: another recent study using the forced swimming test as mousemodel of depression showed the positive effect of the NK3 receptor agonist aminosenktide. Olopatadine Stimulation of the NK3 receptor shortened the time of immobility to the same extent as the prototypic antidepressant desipramine in two out of three investigated mouse lines.81 The anxiolytic effect of NK3 receptor agonists had already been shown by the elevated plus-maze test.56 These antidepressant-like and anxiolytic potencies of NK3 agonist properties may be related to the activation of the endogenous opioid system through NK3 receptor stimulation, as shown previously.82 Clinical pharmacological studies on neurokinin receptor antagonists In 1998, Mark Kramer and colleagues published the first report of a clinical study testing the antidepressant efficacy of an NK1 receptor antagonist.